Atlas Trials

Auricular Point Stimulation Plus Dexamethasone Versus Standard Antiemetic Regimen for Nausea and Vomiting Caused by Trastuzumab Deruxtecan

Clinical trial NCT07716189 · RECRUITING

Trial details

NCT number
NCT07716189
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Nausea and Vomiting Caused by Trastuzumab Deruxtecan
Start date
2025-12-12
Primary completion
2026-12-06
Enrollment
74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.